应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02196 复星医药
未开盘 07-11 16:08:03
17.020
+0.100
+0.59%
最高
17.260
最低
16.920
成交量
670.06万
今开
16.920
昨收
16.920
日振幅
2.01%
总市值
452.56亿
流通市值
92.08亿
总股本
26.59亿
成交额
1.15亿
换手率
1.24%
流通股本
5.41亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
每周股票复盘:复星医药(600196)复迈宁启动新临床试验
证券之星 · 07-12 20:00
每周股票复盘:复星医药(600196)复迈宁启动新临床试验
案例⑬丨复星保德信的中介逻辑:如何打造最懂经代公司的保险公司?
今日保 · 07-12 01:05
案例⑬丨复星保德信的中介逻辑:如何打造最懂经代公司的保险公司?
复星医药:公司资产减值风险较低
证券之星 · 07-11 09:15
复星医药:公司资产减值风险较低
【复星医药:控股子公司复方聚乙二醇电解质散(Ⅱ)药品注册申请获受理】复星医药公告,控股子公司上海朝晖药业有限公司就复方聚乙二醇电解质散(Ⅱ)的药品注册申请获国家药品监督管理局受理。该药品拟用于结肠镜检查、钡灌肠X射线造影和结肠直肠手术前预处理中肠道内容物的排出。截至2025年5月,复星医药集团针对包括该药品在内的复方聚乙二醇电解质散系列药品的累计研发投入约为人民币474万元。2024年,复方聚乙二醇电解质散(Ⅱ)于中国境内(不包括港澳台地区)的销售额约为人民币3.07亿元。
金融界 · 07-11 08:44
【复星医药:控股子公司复方聚乙二醇电解质散(Ⅱ)药品注册申请获受理】复星医药公告,控股子公司上海朝晖药业有限公司就复方聚乙二醇电解质散(Ⅱ)的药品注册申请获国家药品监督管理局受理。该药品拟用于结肠镜检查、钡灌肠X射线造影和结肠直肠手术前预处理中肠道内容物的排出。截至2025年5月,复星医药集团针对包括该药品在内的复方聚乙二醇电解质散系列药品的累计研发投入约为人民币474万元。2024年,复方聚乙二醇电解质散(Ⅱ)于中国境内(不包括港澳台地区)的销售额约为人民币3.07亿元。
每日卖空追踪 | 复星医药 07月11日卖空量成交21.25万股,卖空比例为3.17%
市场透视 · 07-11 08:30
每日卖空追踪 | 复星医药 07月11日卖空量成交21.25万股,卖空比例为3.17%
复星医药07月11日主力净流入971.4万元 散户资金抛售
市场透视 · 07-11 08:16
复星医药07月11日主力净流入971.4万元 散户资金抛售
复星高科计划发行不超过7亿元2年期公司债券
观点网 · 07-10
复星高科计划发行不超过7亿元2年期公司债券
复星医药:全力推进肉毒毒素上市销售前准备
证券之星 · 07-09
复星医药:全力推进肉毒毒素上市销售前准备
复星医药子公司启动复迈宁®儿童脑胶质瘤Ⅲ期临床试验
财中社 · 07-09
复星医药子公司启动复迈宁®儿童脑胶质瘤Ⅲ期临床试验
每日卖空追踪 | 复星医药 07月09日卖空量成交15.45万股,卖空比例为3.11%
市场透视 · 07-09
每日卖空追踪 | 复星医药 07月09日卖空量成交15.45万股,卖空比例为3.11%
复星医药07月09日遭主力抛售115.9万元
市场透视 · 07-09
复星医药07月09日遭主力抛售115.9万元
复星医药:归还4.1亿元闲置募集资金至专项账户
公司公告 · 07-08
复星医药:归还4.1亿元闲置募集资金至专项账户
每日卖空追踪 | 复星医药 07月07日卖空量成交26.4万股,卖空比例为5.64%
市场透视 · 07-07
每日卖空追踪 | 复星医药 07月07日卖空量成交26.4万股,卖空比例为5.64%
复星医药07月07日主力净流出386.0万元 散户资金买入
市场透视 · 07-07
复星医药07月07日主力净流出386.0万元 散户资金买入
青蒿素概念盘中跳水,复星医药跌0.47%
市场透视 · 07-07
青蒿素概念盘中跳水,复星医药跌0.47%
豫园股份股东复地投资解除质押1亿股
财中社 · 07-04
豫园股份股东复地投资解除质押1亿股
每日卖空追踪 | 复星医药 07月04日卖空量成交87.35万股,卖空比例为11.1%
市场透视 · 07-04
每日卖空追踪 | 复星医药 07月04日卖空量成交87.35万股,卖空比例为11.1%
复星医药07月04日获主力加仓116.4万元
市场透视 · 07-04
复星医药07月04日获主力加仓116.4万元
上证180医药卫生指数上涨0.43%,前十大权重包含复星医药等
金融界 · 07-03
上证180医药卫生指数上涨0.43%,前十大权重包含复星医药等
56家上市公司股票获回购,复星医药回购金额最高
第一财经 · 07-03
56家上市公司股票获回购,复星医药回购金额最高
加载更多
公司概况
公司名称:
复星医药
所属市场:
SEHK
上市日期:
--
主营业务:
上海复星医药(集团)股份有限公司是一家主要从事医药产品研发、制造与销售的中国公司。该公司经营五个分部。制药分部主要从事创新药、成熟医药产品制造和疫苗业务。医疗器械与医学诊断分部主要从事分子诊断、免疫诊断、微生物诊断等医疗美容器械的制造和销售。医疗健康服务分部主要从事线上线下一体化医疗服务平台的经营。医药分销和零售分部主要从事医药产品的批发零售。其他分部从事其他医药相关业务。该公司的产品主要用于肿瘤、免疫、中枢神经等治疗领域。
发行价格:
--
{"stockData":{"symbol":"02196","market":"HK","secType":"STK","nameCN":"复星医药","latestPrice":17.02,"timestamp":1752221283030,"preClose":16.92,"halted":0,"volume":6700552,"delay":0,"floatShares":541000000,"shares":2659000000,"eps":1.1348566576981038,"marketStatus":"未开盘","change":0.1,"latestTime":"07-11 16:08:03","open":16.92,"high":17.26,"low":16.92,"amount":114653759,"amplitude":0.020095,"askPrice":17.06,"askSize":13500,"bidPrice":17.02,"bidSize":73500,"shortable":3,"etf":0,"ttmEps":1.1999358705732766,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752456600000},"marketStatusCode":0,"adr":0,"listingDate":1351526400000,"exchange":"SEHK","adjPreClose":16.92,"dividendRate":0.017626,"openAndCloseTimeList":[[1752197400000,1752206400000],[1752210000000,1752220800000]],"volumeRatio":1.3231749253599128,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600196","market":"SH","secType":"STK","nameCN":"复星医药","latestPrice":25.6,"timestamp":1752217200000,"preClose":25.43,"halted":0,"volume":23942300,"delay":0,"premium":"-39.23"}},"requestUrl":"/m/hq/s/02196","defaultTab":"news","newsList":[{"id":"2551919976","title":"每周股票复盘:复星医药(600196)复迈宁启动新临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2551919976","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551919976?lang=zh_cn&edition=full","pubTime":"2025-07-13 04:00","pubTimestamp":1752350434,"startTime":"0","endTime":"0","summary":"截至2025年7月11日收盘,复星医药报收于25.6元,较上周的25.43元上涨0.67%。本周,复星医药7月10日盘中最高价报26.05元。复星医药当前最新总市值683.63亿元,在化学制药板块市值排名6/150,在两市A股市值排名208/5149。本周关注点公司公告汇总:复星医药启动复迈宁治疗儿童低级别脑胶质瘤的Ⅲ期临床试验公司公告汇总复星医药关于控股子公司药品临床试验进展的公告指出,近日启动了复迈宁用于治疗儿童低级别脑胶质瘤在中国境内的Ⅲ期临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071300000715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03347","BK1593","600196","BK0096","BK0028","BK1141","BK0188","BK0175","BK0187","BK0012","BK0239","BK0060","BK0196","BK1583","BK1576","02196","BK0183","BK1191","BK1515"],"gpt_icon":0},{"id":"2550599830","title":"案例⑬丨复星保德信的中介逻辑:如何打造最懂经代公司的保险公司?","url":"https://stock-news.laohu8.com/highlight/detail?id=2550599830","media":"今日保","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550599830?lang=zh_cn&edition=full","pubTime":"2025-07-12 09:05","pubTimestamp":1752282329,"startTime":"0","endTime":"0","summary":"截至2024年,复星保德信在全国设立6家省级机构、20余家营业网点,年度保险业务收入92.51亿元,新业务价值实现200%的增长。2024年,复星保德信实现规模保费37.9亿元,标准保费11.6亿元。复星保德信的中介战略:聚焦“产品+生态+高客+服务+温度”复星保德信致力于打造“最懂经代公司的保险公司”和“最宠代理人的保险公司”,因此推出“产品+生态+高客+服务+温度”的中介战略。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712091213a445c6cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712091213a445c6cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600196","02196","00656","BK1230"],"gpt_icon":0},{"id":"2550935216","title":"复星医药:公司资产减值风险较低","url":"https://stock-news.laohu8.com/highlight/detail?id=2550935216","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550935216?lang=zh_cn&edition=full","pubTime":"2025-07-11 17:15","pubTimestamp":1752225312,"startTime":"0","endTime":"0","summary":"证券之星消息,复星医药07月11日在投资者关系平台上答复投资者关心的问题。近年来,公司固定资产和无形资产规模增长,主要源于战略导向下的长期投入。资产管理方面,公司遵循会计政策和内控制度,包括计提固定资产及无形资产的折旧、摊销和执行减值测试等程序。同时,公司通过持续优化资产结构,推动提升资产效能与市场竞争力。基于这些措施,公司资产减值风险较低。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071100028384.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","BK0183","BK1515","BK0060","BK0188","BK0175","BK0096","BK1191","BK0028","BK0196","BK0012","BK0239","02196","600196","BK1593"],"gpt_icon":0},{"id":"2550229980","title":"【复星医药:控股子公司复方聚乙二醇电解质散(Ⅱ)药品注册申请获受理】复星医药公告,控股子公司上海朝晖药业有限公司就复方聚乙二醇电解质散(Ⅱ)的药品注册申请获国家药品监督管理局受理。该药品拟用于结肠镜检查、钡灌肠X射线造影和结肠直肠手术前预处理中肠道内容物的排出。截至2025年5月,复星医药集团针对包括该药品在内的复方聚乙二醇电解质散系列药品的累计研发投入约为人民币474万元。2024年,复方聚乙二醇电解质散(Ⅱ)于中国境内(不包括港澳台地区)的销售额约为人民币3.07亿元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2550229980","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550229980?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:44","pubTimestamp":1752223448,"startTime":"0","endTime":"0","summary":"复星医药公告,控股子公司上海朝晖药业有限公司就复方聚乙二醇电解质散(Ⅱ)的药品注册申请获国家药品监督管理局受理。该药品拟用于结肠镜检查、钡灌肠X射线造影和结肠直肠手术前预处理中肠道内容物的排出。截至2025年5月,复星医药集团针对包括该药品在内的复方聚乙二醇电解质散系列药品的累计研发投入约为人民币474万元。2024年,复方聚乙二醇电解质散(Ⅱ)于中国境内(不包括港澳台地区)的销售额约为人民币3.07亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/07/11164451632515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0196","BK0239","BK1515","02196","BK0188","BK0028","BK1191","BK0096","BK0183","BK0187","600196","BK0012","BK1593","BK0060","BK0175"],"gpt_icon":0},{"id":"2550936193","title":"每日卖空追踪 | 复星医药 07月11日卖空量成交21.25万股,卖空比例为3.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550936193","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550936193?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:30","pubTimestamp":1752222628,"startTime":"0","endTime":"0","summary":"复星医药北京时间07月11日,涨0.59%,卖空量成交21.25万股%,较上一交易日减少8.99%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711172508a6a37dfb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711172508a6a37dfb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1593","BK1191","02196"],"gpt_icon":0},{"id":"2550936165","title":"复星医药07月11日主力净流入971.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2550936165","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550936165?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:16","pubTimestamp":1752221762,"startTime":"0","endTime":"0","summary":"07月11日, 复星医药股价涨0.59%,报收17.02元,成交金额1.1亿元,换手率1.24%,振幅2.01%,量比1.32。复星医药今日主力资金净流入971.4万元,上一交易日主力净流出1256.1万元。该股近5个交易日下跌0.35%,主力资金累计净流出899.3万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出6630.8万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711171034a6a373db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711171034a6a373db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02196","BK1191","BK1593","BK1515"],"gpt_icon":0},{"id":"2550617168","title":"复星高科计划发行不超过7亿元2年期公司债券","url":"https://stock-news.laohu8.com/highlight/detail?id=2550617168","media":"观点网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550617168?lang=zh_cn&edition=full","pubTime":"2025-07-10 17:02","pubTimestamp":1752138120,"startTime":"0","endTime":"0","summary":"观点网讯:7月10日,上海复星高科技(集团)有限公司发布公告,宣布2025年面向专业投资者公开发行公司债券(第一期)的发行计划。此次债券发行规模不超过7亿元,票面金额及发行价格为100元/张,按面值平价发行,债券期限为2年期,并附第1年末发行人调整票面利率选择权和投资者回售选择权。此次债券的票面利率询价区间为3.50%-4.10%,最终利率将由簿记建档结果确定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710170652953d4074&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710170652953d4074&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","02196","BK1593","600196","00656"],"gpt_icon":0},{"id":"2550524638","title":"复星医药:全力推进肉毒毒素上市销售前准备","url":"https://stock-news.laohu8.com/highlight/detail?id=2550524638","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550524638?lang=zh_cn&edition=full","pubTime":"2025-07-09 17:30","pubTimestamp":1752053434,"startTime":"0","endTime":"0","summary":"证券之星消息,复星医药(600196)07月09日在投资者关系平台上答复投资者关心的问题。投资者提问:公司肉毒素获批已经有10个月,至今还未上市,请问这是烂尾了吗?复星医药回复:投资者您好!公司正在全力推进注射用A型肉毒毒素(中国境内商标:达希斐)于中国境内上市销售前的各项准备工作。感谢您对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070900028284.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","BK0012","02196","BK0196","BK0239","BK1593","BK0060","600196","BK1191","BK1515","BK0175","BK0028","BK0096","BK0183","BK0188"],"gpt_icon":0},{"id":"2550069684","title":"复星医药子公司启动复迈宁®儿童脑胶质瘤Ⅲ期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2550069684","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550069684?lang=zh_cn&edition=full","pubTime":"2025-07-09 16:37","pubTimestamp":1752050252,"startTime":"0","endTime":"0","summary":"7月9日,复星医药发布公告,控股子公司药品临床试验进展情况。公告指出,该公司控股子公司上海复星医药产业发展有限公司已启动复迈宁用于治疗儿童低级别脑胶质瘤的Ⅲ期临床试验。与此同时,该药品用于成人Ⅰ型神经纤维瘤病和儿童低级别脑胶质瘤的临床试验均处于Ⅲ期阶段,涉及的其他适应症也在进行相关临床试验。2025年一季度,复星医药实现收入94.20亿元,归母净利润7.65亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709163825953bec38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709163825953bec38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02196","BK1576","03347","BK1191","BK1141","BK1593","BK1515","BK1583"],"gpt_icon":0},{"id":"2550068076","title":"每日卖空追踪 | 复星医药 07月09日卖空量成交15.45万股,卖空比例为3.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550068076","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550068076?lang=zh_cn&edition=full","pubTime":"2025-07-09 16:30","pubTimestamp":1752049829,"startTime":"0","endTime":"0","summary":"复星医药北京时间07月09日,跌0.59%,卖空量成交15.45万股%,较上一交易日增加3.69%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709172349a69f196a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709172349a69f196a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02196","BK1593","BK1515"],"gpt_icon":0},{"id":"2550597687","title":"复星医药07月09日遭主力抛售115.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550597687","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550597687?lang=zh_cn&edition=full","pubTime":"2025-07-09 16:15","pubTimestamp":1752048937,"startTime":"0","endTime":"0","summary":"07月09日, 复星医药股价跌0.59%,报收16.80元,成交金额8393.3万元,换手率0.92%,振幅2.72%,量比0.86。复星医药今日主力资金净流出115.9万元,连续3日净流出,上一交易日主力净流出112.7万元。该股近5个交易日下跌0.47%,主力资金累计净流出221.0万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出6145.4万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709165756a43ff2d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709165756a43ff2d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02196","BK1593","BK1191","BK1515"],"gpt_icon":0},{"id":"2549548122","title":"复星医药:归还4.1亿元闲置募集资金至专项账户","url":"https://stock-news.laohu8.com/highlight/detail?id=2549548122","media":"公司公告","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549548122?lang=zh_cn&edition=full","pubTime":"2025-07-08 17:25","pubTimestamp":1751966749,"startTime":"0","endTime":"0","summary":"复星医药公告,截至2025年7月7日,募投实施主体已将用于暂时补充流动资金的4.1亿元全部归还至募集资金专项账户,并通知保荐机构及代表人。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708172927a69cdd2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708172927a69cdd2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02196","BK1593","600196","BK1515","BK1191"],"gpt_icon":0},{"id":"2549538378","title":"每日卖空追踪 | 复星医药 07月07日卖空量成交26.4万股,卖空比例为5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549538378","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549538378?lang=zh_cn&edition=full","pubTime":"2025-07-07 16:30","pubTimestamp":1751877028,"startTime":"0","endTime":"0","summary":"复星医药北京时间07月07日,跌2.22%,卖空量成交26.4万股%,较上一交易日减少81.87%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707171950a43b8373&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707171950a43b8373&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","02196","BK1191","BK1593"],"gpt_icon":0},{"id":"2549858229","title":"复星医药07月07日主力净流出386.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2549858229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549858229?lang=zh_cn&edition=full","pubTime":"2025-07-07 16:15","pubTimestamp":1751876149,"startTime":"0","endTime":"0","summary":"07月07日, 复星医药股价跌2.22%,报收16.70元,成交金额7860.2万元,换手率0.87%,振幅2.81%,量比0.65。复星医药今日主力资金净流出386.0万元,上一交易日主力净流入116.4万元。该股近5个交易日上涨2.47%,主力资金累计净流入684.4万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出9161.0万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707165933a69a9d72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707165933a69a9d72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1191","BK1515","02196"],"gpt_icon":0},{"id":"2549500303","title":"青蒿素概念盘中跳水,复星医药跌0.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549500303","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549500303?lang=zh_cn&edition=full","pubTime":"2025-07-07 09:57","pubTimestamp":1751853470,"startTime":"0","endTime":"0","summary":"07月07日,青蒿素概念盘中跳水,截至09点57分,青蒿素概念整体指数下跌0.50%,报1277.850点。从个股上来看,该概念的成分股中,复星医药跌0.47%,昆药集团、华润双鹤、白云山跌幅居前。从资金上来看,截止发稿,青蒿素概念主力净流入为-249.90万,其中新 和 成受到资金热捧,主力净流入2332.29万;拉长时间线来看,该板块近20日主力资金净流入-7.35亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507070957509538fa36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507070957509538fa36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1515","600196","BK1191","02196"],"gpt_icon":0},{"id":"2548699369","title":"豫园股份股东复地投资解除质押1亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=2548699369","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548699369?lang=zh_cn&edition=full","pubTime":"2025-07-04 16:56","pubTimestamp":1751619360,"startTime":"0","endTime":"0","summary":"7月4日,豫园股份(600655)发布公告,控股股东上海复星高科技(集团)有限公司下属的复地投资管理有限公司于2025年7月3日解除质押股份1亿股,占其所持股份的9.77%及公司总股本的2.57%。解除质押后,复地投资累计质押股份为4.62亿股,占其所持股份的45.12%及公司总股本的11.85%。截至公告披露日,复星高科技及其一致行动人合计持有公司股份数量为24.1亿股,占公司总股本的61.84%,累计质押股份为15.59亿股,占其持有股份的64.68%。2025年一季度,豫园股份实现收入87.82亿元,归母净利润5183万元。(文章来源:财中社)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507041659219799b2b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507041659219799b2b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","02196","BK0187","600655","BK0012","BK0102","BK0053","BK0127","BK0209","BK0060","BK0196","BK0239","600196","BK0183","BK0028","BK0096","BK0175"],"gpt_icon":0},{"id":"2548511360","title":"每日卖空追踪 | 复星医药 07月04日卖空量成交87.35万股,卖空比例为11.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548511360","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548511360?lang=zh_cn&edition=full","pubTime":"2025-07-04 16:30","pubTimestamp":1751617830,"startTime":"0","endTime":"0","summary":"复星医药北京时间07月04日,涨1.07%,卖空量成交87.35万股%,较上一交易日减少8.44%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704172218a4369f53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704172218a4369f53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","BK1593","02196"],"gpt_icon":0},{"id":"2548360513","title":"复星医药07月04日获主力加仓116.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548360513","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548360513?lang=zh_cn&edition=full","pubTime":"2025-07-04 16:15","pubTimestamp":1751616946,"startTime":"0","endTime":"0","summary":"07月04日, 复星医药股价涨1.07%,报收17.08元,成交金额1.3亿元,换手率1.45%,振幅1.78%,量比1.04。复星医药今日主力资金净流入116.4万元,上一交易日主力净流入277.2万元。该股近5个交易日上涨6.09%,主力资金累计净流入1405.7万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出9463.6万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704170312a43692b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704170312a43692b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","BK1593","02196"],"gpt_icon":0},{"id":"2548385214","title":"上证180医药卫生指数上涨0.43%,前十大权重包含复星医药等","url":"https://stock-news.laohu8.com/highlight/detail?id=2548385214","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548385214?lang=zh_cn&edition=full","pubTime":"2025-07-03 23:13","pubTimestamp":1751555611,"startTime":"0","endTime":"0","summary":"金融界7月3日消息,上证指数高开震荡,上证180医药卫生指数 上涨0.43%,报4968.85点,成交额48.83亿元。数据统计显示,上证180医药卫生指数近一个月下跌1.12%,近三个月上涨2.30%,年至今上涨9.52%。从上证180医药卫生指数持仓样本的行业来看,医药卫生占比100.00%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/03231351469678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0060","02196","BK0188","BK1191","BK0196","600196","BK1515","BK1593","BK0187","BK0028","BK0239","BK0096","BK0012","BK0175","BK0183","000010.SH"],"gpt_icon":0},{"id":"2548383507","title":"56家上市公司股票获回购,复星医药回购金额最高","url":"https://stock-news.laohu8.com/highlight/detail?id=2548383507","media":"第一财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548383507?lang=zh_cn&edition=full","pubTime":"2025-07-03 22:44","pubTimestamp":1751553862,"startTime":"0","endTime":"0","summary":"Wind数据显示,7月3日,56家上市公司回购股票,其中复星医药回购金额最高达1.73亿元,回购数量692万股,贵州茅台回购金额达1.02亿元,回购数量7.2万股,正泰电器回购金额达8669元,回购数量385万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070322442295355b6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070322442295355b6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1593","02196","BK1191"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fosunpharma.com","stockEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":-0.0128},{"period":"3month","weight":0.2262},{"period":"6month","weight":0.2933},{"period":"1year","weight":0.2979},{"period":"ytd","weight":0.2054}],"compareEarnings":[{"period":"1week","weight":0.0093},{"period":"1month","weight":-0.0093},{"period":"3month","weight":0.1542},{"period":"6month","weight":0.2662},{"period":"1year","weight":0.3537},{"period":"ytd","weight":0.2034}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海复星医药(集团)股份有限公司是一家主要从事医药产品研发、制造与销售的中国公司。该公司经营五个分部。制药分部主要从事创新药、成熟医药产品制造和疫苗业务。医疗器械与医学诊断分部主要从事分子诊断、免疫诊断、微生物诊断等医疗美容器械的制造和销售。医疗健康服务分部主要从事线上线下一体化医疗服务平台的经营。医药分销和零售分部主要从事医药产品的批发零售。其他分部从事其他医药相关业务。该公司的产品主要用于肿瘤、免疫、中枢神经等治疗领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.384615,"avgChangeRate":-0.051332},{"month":2,"riseRate":0.769231,"avgChangeRate":0.040452},{"month":3,"riseRate":0.615385,"avgChangeRate":0.048435},{"month":4,"riseRate":0.384615,"avgChangeRate":0.03075},{"month":5,"riseRate":0.461538,"avgChangeRate":0.035269},{"month":6,"riseRate":0.461538,"avgChangeRate":-0.026537},{"month":7,"riseRate":0.615385,"avgChangeRate":0.016133},{"month":8,"riseRate":0.25,"avgChangeRate":-0.056338},{"month":9,"riseRate":0.416667,"avgChangeRate":-0.002922},{"month":10,"riseRate":0.5,"avgChangeRate":0.028405},{"month":11,"riseRate":0.461538,"avgChangeRate":0.046299},{"month":12,"riseRate":0.461538,"avgChangeRate":0.021542}],"exchange":"SEHK","name":"复星医药","nameEN":"FOSUN PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"复星医药(02196)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供复星医药(02196)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"复星医药,02196,复星医药股票,复星医药股票老虎,复星医药股票老虎国际,复星医药行情,复星医药股票行情,复星医药股价,复星医药股市,复星医药股票价格,复星医药股票交易,复星医药股票购买,复星医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"复星医药(02196)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供复星医药(02196)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}